Skip to content

A Comparison of the Outcomes in Fortiva and Strattice Mesh

A Comparison of the Outcomes in Fortiva and Strattice Mesh

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05572021
Enrollment
6
Registered
2022-10-07
Start date
2023-09-25
Completion date
2025-03-21
Last updated
2025-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventral Hernia

Keywords

ventral hernia, surgical biologic mesh, hernia complications

Brief summary

A comparison of ventral hernia repair with Strattice and Fortiva mesh.Primary The study team aims to determine the hernia recurrence rates for RTI Surgical biologic mesh (Fortiva) compared to Strattice. Also the study team aims to determine the mesh related complications for RTI Surgical biologic mesh (Fortiva) compared to Strattice

Detailed description

This study will be a prospective, matched study of patients using Fortiva biologic mesh to determine the rates of hernia recurrence and mesh related complication compared to Strattice mesh. Patients who meet the inclusion and exclusion criteria will be prospectively enrolled to receive a Ventral Hernia Repair (VHR) using Fortiva biologic mesh and will be compared to a retrospective cohort of patients with a VHR that utilized Strattice mesh. Patients will be propensity matched in a 1:3 (Fortiva : Strattice) fashion based on age, sex, and hernia defect size.

Interventions

DEVICEProspective Ventral Hernia Repair with Fortiva

Ventral hernia repair using Fortiva biologic mesh

DEVICERetroSpective Ventral Hernia Repair with Strattice

Retrospective cohort of ventral hernia repair patients using Strattice mesh

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Comparison of prospective group to retrospective group

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Ventral Hernia requiring surgical repair

Exclusion criteria

* Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Frequency of Participants With a Hernia Recurrence1 year follow up post surgical repairFrequency of participants with a hernia recurrence
Percentage of Participants With a Hernia Recurrence1 year follow up post surgical repairPercentage of participants with a hernia recurrence

Secondary

MeasureTime frameDescription
Number of Participants With a Mesh Related Complication1 year follow up post surgical repairNumber of participants with a mesh related complication
Percent of Participants With a Mesh Related Complication1 year follow up post surgical repairPercent of participants with a mesh related complication

Countries

United States

Participant flow

Recruitment details

This study planned to use matched analysis matching the prospective and retrospective arms. For studies of this fashion all prospective participants are enrolled first to sample size and then matching retrospective patients are enrolled. It is not a standard practice to match patients as they enroll. This study was terminated before prospective arm enrollment was completed. Therefore, no participants were enrolled in the retrospective arm.

Participants by arm

ArmCount
Prospective
Participants enrolled to ventral hernia repair with Fortiva mesh Prospective ventral hernia repair with Fortiva: Ventral hernia repair using Fortiva biologic mesh
6
Retrospective
Retrospective participants with ventral hernia repair using Strattice mesh RetroSpective ventral hernia repair with Strattice: Retrospective cohort of ventral hernia repair patients using Strattice mesh
0
Total6

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyStudy terminated - PI left the institution and no other surgeons were interested in continuing study50

Baseline characteristics

CharacteristicTotalProspective
Age, Continuous66.0 years
STANDARD_DEVIATION 6.8
66.0 years
STANDARD_DEVIATION 6.8
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
6 Participants6 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants
Race (NIH/OMB)
White
6 Participants6 Participants
Sex: Female, Male
Female
4 Participants4 Participants
Sex: Female, Male
Male
2 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 60 / 0
other
Total, other adverse events
0 / 60 / 0
serious
Total, serious adverse events
0 / 60 / 0

Outcome results

Primary

Frequency of Participants With a Hernia Recurrence

Frequency of participants with a hernia recurrence

Time frame: 1 year follow up post surgical repair

Population: This study planned to use matched analysis matching the prospective and retrospective arms. For studies of this fashion all prospective participants are enrolled first to sample size and then matching retrospective patients are enrolled. It is not a standard practice to match patients as they enroll. This study was terminated before prospective arm enrollment was completed. Therefore, no participants were enrolled in the retrospective arm.

ArmMeasureValue (NUMBER)
ProspectiveFrequency of Participants With a Hernia Recurrence0 occurrence
Primary

Percentage of Participants With a Hernia Recurrence

Percentage of participants with a hernia recurrence

Time frame: 1 year follow up post surgical repair

Population: This study planned to use matched analysis matching the prospective and retrospective arms. For studies of this fashion all prospective participants are enrolled first to sample size and then matching retrospective patients are enrolled. It is not a standard practice to match patients as they enroll. This study was terminated before prospective arm enrollment was completed. Therefore, no participants were enrolled in the retrospective arm.

ArmMeasureValue (NUMBER)
ProspectivePercentage of Participants With a Hernia Recurrence0 percentage of participants
Secondary

Number of Participants With a Mesh Related Complication

Number of participants with a mesh related complication

Time frame: 1 year follow up post surgical repair

Population: This study planned to use matched analysis matching the prospective and retrospective arms. For studies of this fashion all prospective participants are enrolled first to sample size and then matching retrospective patients are enrolled. It is not a standard practice to match patients as they enroll. This study was terminated before prospective arm enrollment was completed. Therefore, no participants were enrolled in the retrospective arm.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ProspectiveNumber of Participants With a Mesh Related Complication0 Participants
Secondary

Percent of Participants With a Mesh Related Complication

Percent of participants with a mesh related complication

Time frame: 1 year follow up post surgical repair

Population: This study planned to use matched analysis matching the prospective and retrospective arms. For studies of this fashion all prospective participants are enrolled first to sample size and then matching retrospective patients are enrolled. It is not a standard practice to match patients as they enroll. This study was terminated before prospective arm enrollment was completed. Therefore, no participants were enrolled in the retrospective arm.

ArmMeasureValue (NUMBER)
ProspectivePercent of Participants With a Mesh Related Complication0 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026